Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3614_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
73 Мб
Скачать
SECTION 1 Pathophysiology and investigation ofcoronary artery disease48
https://t.me/medicina_free
with known or suspected coronary artery disease:a systematic review and meta- analysis. J Am Coll Cardiol. 2013;62(9):826– 38.
3. Gargiulo P, Dellegrottaglie S, Bruzzese D, Savarese G, Scala O, Ruggiero D, etal. e prognostic value of normal stress cardiac magnetic resonance in patients with known or suspected coronary artery disease:a meta- analysis. Circ Cardiovasc Imaging. 2013;6(4):574– 82.
4. Manka R, Jahnke C, Kozerke S, Vitanis V, Crelier G, Gebker R, etal. Dynamic 3- dimensional stress cardiac magnetic resonance perfusion imaging:detection of coronary artery disease and volumetry of myocardial hypoenhancement before and aer coronary stenting. J Am Coll Cardiol. 2011;57(4):437– 44.
5. Manka R, Wissmann L, Gebker R, Jogiya R, Motwani M, Frick M, etal. Multicenter evaluation of dynamic three­dimensional magnetic resonance myocardial perfusion imaging for the detection of coronary artery disease defined by fractional flow reserve. Circ Cardiovasc Imaging. 2015;8(5):e003061.
6. Bettencourt N, Ferreira N, Chiribiri A, Schuster A, Sampaio F, Santos L, etal. Additive value of magnetic resonance coronary angiography in a comprehensive cardiac magnetic resonance stress- rest protocol for detection of functionally signicant coronary artery disease:a pilot study. Circ Cardiovasc Imaging. 2013;6(5):730– 8.
7. Gotschy A, Wissmann L, Goolaub DS, Niemann M, Hamada S, Kozerke S, etal. First fusion and combined evaluation of 3D­CMR perfusion with 3D- MR coronary angiography. Int J Cardiol. 2016;202:62– 3.
8. Schwitter J, Wacker CM, van Rossum AC, Lombardi M, Al- Saadi N, Ahlstrom H, etal. MR- IMPACT:comparison of perfusion­cardiac magnetic resonance with single- photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J. 2008;29(4):480– 9.
9. Klein C, Nagel E, Gebker R, Kelle S, Schnackenburg B, Graf K, etal. Magnetic resonance adenosine perfusion imaging in patients aer coronary artery bypass gra surgery. JACC Cardiovasc Imaging. 2009;2(4):437– 45.
10. Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, etal. Cardiovascular magnetic resonance and single- photon emission computed tomography for diagnosis of coronary heart disease (CE- MARC):a prospective trial. Lancet. 2012;379(9814):453– 60.
11. Nagel E, Lehmkuhl HB, Bocksch W, Klein C, Vogel U, Frantz E, etal. Noninvasive diagnosis of ischemia- induced wall motion abnormalities with the use of high- dose dobutamine stress MRI:comparison with dobutamine stress echocardiography. Circulation. 1999;99(6):763– 70.
12. Manka R, Jahnke C, Gebker R, Schnackenburg B, Paetsch I. Head- to- head comparison of rst- pass MR perfusion imaging during adenosine and high- dose dobutamine/ atropine stress. Int J Cardiovasc Imaging. 2011;27(7):995– 1002.
13. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, etal. e use of contrast- enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343(20):1445– 53.
14. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, etal. Contrast- enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts:an imaging study. Lancet. 2003;361(9355):374– 9.
5.4 Cardiac computedtomography
Steve L. Liao
Introduction
Rapid technological advances have allowed for the application of computed tomography (CT) imaging for the evaluation of the heart. Cardiac CT scanning is now a standard method to investigate the anatomical structure of the heart and most commonly, the coronary vasculature, given the prevalence of coronary artery disease (CAD) and its associated morbidity and mortality. Due to the heart’s con­stant motion and the relatively small luminal diameters of the cor­onary arteries, scanning the heart and coronaries by CT presents unique challenges for image acquisition normally not encountered when imaging other anatomical areas.
Background ofcardiac computedtomography
A CT scanner acquires cross- sectional images axially, either in a continuous fashion in the case of a retrospectively gated scan or in a step- and- shoot fashion in the case of a prospectively gated scan. Gating of the scan via the patient’s electrocardiogram is crucial and unique to cardiac CT, permitting the images to be obtained during cardiac diastole, when the heart is most still. Other techniques com­monly used to optimize image quality include a breath- hold during imaging acquisition and the administration of sublingual nitrogly­cerine and beta blockers prior to the scan. Employing these tech­niques improves image quality and reduces imaging artifacts most commonly attributed to motion.
Improvements in CT scanner technology have resulted in incre­mental improvements in temporal, spatial, and contrast resolution facilitating a more accurate interrogation of the coronary lumen with a concomitant reduction in the overall administered radiation dose. Driven by increases in the size and number of detectors used in CT scanning, better imaging resolution has progressively improved the diagnostic accuracy of CT in cardiac imaging.
Clinical use incardiology
Clinical use of cardiac CT scanning has focused primarily on the diagnosis of CAD and can take the form of either a non- contrast study in the case of a coronary artery calcium (CAC) score or an intravenous contrast study in the case of a coronary CT angiogram (CCTA). Other uses of cardiac CT include preprocedural imaging of the le atrium prior to atrial brillation ablation and of the aorta and vasculature prior to transcatheter aortic valve replacement. Cardiac CT can also be helpful in the evaluation of coronary anomalies and in structural heart disease by assessing cardiac size and function when retrospective gating is utilized.
CACscore
Coronary artery calcication develops as part of the pathogenesis of coronary atherosclerosis and is absent in normal vessel walls. e
5.4 Cardiac computedtomography 49
https://t.me/medicina_free
Fig.5.4.1 Multiplanar reconstructions of a normal left main and left anterior descending coronary artery (top red arrow) and of the right coronary
artery (bottom yellow arrow).
CAC score is obtained via a non- contrast CT scan or by electron beam CT. e Multi- Ethnic Study of Atherosclerosis (MESA) inves­tigated the relationship between coronary calcication and future coronary events in four major ethnic groups and found that the CAC score predicted the incidence of heart disease, providing predictive information beyond that obtained from the standard Framingham risk factors. ere has been debate about the appropriate clinical application for the CAC score, despite its predictive value, given the lack of prospective data showing improvement in outcomes with therapy.
CCTA
CCTA provides high- quality diagnostic images of the coronary vasculature non- invasively (Fig. 5.4.1) and can help characterize the type, location, and extent of plaque within the coronary artery (Fig. 5.4.2). Indeed, numerous studies have demonstrated the ability of this modality to accurately diagnose obstructive CAD. Additionally, each subsequent generation of scanner improves on the diagnostic quality and accuracy achieved by the previous gen­eration., e pooled sensitivity and specicity has been reported
to be 98% and 91%, respectively. CCTA also provides an accurate means to non- invasively assess the patency of coronary arty bypass gras. As gras usually experience less motion and, in the case of saphenous venous gras, can be larger in calibre, a high sensitivity and specicity are observed with the use of CCTA for gra interro­gation.–  Importantly, the extent and the severity of CAD as de­tected by CCTA have been shown to have prognostic signicance.
A natural application of this technology can be found in assessing patients presenting to the emergency department with a chest pain syndrome. e use of CCTA in the emergency department was shown to improve the eciency of clinical decision- making com­pared to standard evaluation in this setting but had no eect on overall cost of care. Additionally, CCTA eectively triaged those patients with a low- to- intermediate clinical risk of obstructive CAD to a safe and expedited discharge. Amore recent and larger ran­domized but open trial showed that CCTA was able to accurately diagnose obstructive CAD and resulted in a reduction in the need for stress testing. is study showed an increased usage of cardiac catheterization to target interventions of obstructive CAD detected by CCTA.
SECTION 1 Pathophysiology and investigation ofcoronary artery disease50
https://t.me/medicina_free
Fig.5.4.2 Multiplanar reconstructions of a left anterior descending coronary artery with significant obstructive disease consisting of calcified and
non- calcified plaques (top red arrow) and of the right coronary artery with obstructive disease consisting primarily of non- calcified disease (bottom yellow arrow).
A large randomized trial investigated the use of CCTA in symp­tomatic patients without diagnosed CAD, in a non- urgent set­ting. is study compared an initial approach using CCTA against standard functional testing (exercise electrocardiography, nuclear stress testing, or stress echocardiography). CCTA did not improve
are still ongoing, recent randomized trials failed to show super­iority of CCTA over functional testing, suggesting that even in this age of impressive technological advances, a physician’s clin­ical judgement in selecting the appropriate test for a specic pa-
tient remains vital. clinical outcomes compared with functional testing over a period of approximately 2years, with the caveat that the overall event rates were low, 3.1%. Interestingly, in contrast to the previous study, this study showed that CCTA led to fewer catheterizations than did functional testing.
e future of cardiac CT is bright. Of the dierent applica­tions and techniques that are being developed, the calculation of fractional ow reserve from CCTA is showing itself to be a promising technique. Its use in conjunction with CCTA is being studied as a replacement for diagnostic cardiac catheterization in patients referred for coronary artery bypass graing. Cardiac CT has evolved rapidly and has demonstrated the ability to accur­ately diagnose CAD and help with prognosticating future events. While studies comparing dierent CAD assessment modalities
REFERENCES
1. Mahesh M, Cody DD. Physics of cardiac imaging with multiple­row detector CT. RadioGraphics. 2007;27(5):1495– 509.
2. Kalisz K, Buethe J, Saboo SS, Abbara S, Halliburton S, Rajiah P. Artifacts at cardiac CT:physics and solutions. RadioGraphics. 2016;36(7):2064– 83.
3. Vanhoenacker PK, Heijenbrok- Kal MH, Van Heste R, Decramer I, Van Hoe LR, Wijns W, etal. Diagnostic performance of multidetector CT angiography for assessment of coronary artery disease:meta- analysis. Radiology. 2007;244(2):419– 28.
4. Greenland P, Bonow RO, Brundage BH, Budo MJ, Eisenberg MJ, Grundy SM, etal. ACCF/ AHA 2007 clinical expert consensus
5.4 Cardiac computedtomography 51
https://t.me/medicina_free
document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain:a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/ AHA Writing Committee to Update the 2000 expert consensus document on electron beam computed tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2007;49(3):378– 402.
5. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, etal. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358(13):1336– 45.
6. Redberg RF. What is the prognostic value of a zero calcium score? J Am Coll Cardiol. 2010;55(7):635– 6.
7. Garcia MJ, Lessick J, Homann MH, CATSCAN Study Investigators. Accuracy of 16- row multidetector computed tomography for the assessment of coronary artery stenosis. JAMA. 2006;296(4):403– 11.
8. Miller JM, Rochitte CE, Dewey M, Arbab- Zadeh A, Niinuma H, Gottlieb I, etal. Diagnostic performance of coronary angiography by 64- row CT. N Engl J Med. 2008;359(22):2324– 36.
9. Menke J, Unterberg- Buchwald C, Staab W, Sohns JM, Seif Amir Hosseini A, Schwarz A. Head- to- head comparison of prospectively triggered vs retrospectively gated coronary computed tomography angiography:meta- analysis of diagnostic accuracy, image quality, and radiation dose. Am Heart J. 2013;165(2):154– 63.e3.
10. Nieman K, Pattynama PM, Rensing BJ, Van Geuns RJ, De Feyter PJ. Evaluation of patients aer coronary artery bypass surgery:CT angiographic assessment of gras and coronary arteries. Radiology. 2003;229(3):749– 56.
11. Ropers D, Pohle FK, Kuettner A, Pederer T, Anders K, Daniel WG, etal. Diagnostic accuracy of noninvasive coronary angiography in patients aer bypass surgery using 64- slice spiral computed tomography with 330- ms gantry rotation. Circulation. 2006;114(22):2334– 41.
12. Gramer BM, Diez Martinez P, Chin AS, Sylvestre MP, Larrivée S, Stevens LM, etal. 256- Slice CT angiographic evaluation of
coronary artery bypass gras:eect of heart rate, heart rate variability and Z- axis location on image quality. PLoS One. 2014;9(3):e91861.
13. Cho I, Chang HJ, Sung JM, Pencina MJ, Lin FY, Dunning AM, etal. Coronary computed tomographic angiography and risk of all- cause mortality and nonfatal myocardial infarction in subjects without chest pain syndrome from the CONFIRM Registry (coronary CT angiography evaluation for clinical outcomes:an International Multicenter Registry). Circulation. 2012;126(3):304– 13.
14. Homann U, Truong QA, Schoenfeld DA, Chou ET, Woodard PK, Nagurney JT, etal. Coronary CT angiography versus standard evaluation in acute chest pain. N Engl J Med. 2012;367(4):299– 308.
15. Litt HI, Gatsonis C, Snyder B, Singh H, Miller CD, Entrikin DW, etal. CT angiography for safe discharge of patients with possible acute coronary syndromes. N Engl J Med. 2012;366(15):1393– 403.
16. SCOT- HEART investigators. CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT- Heart):an open- label, parallel- group, multicentre trial. Lancet. 2015;385(9985):2383– 91.
17. Douglas PS, Homann U, Patel MR, Mark DB, Al- Khalidi HR, Cavanaugh B, etal. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med. 2015;372(14):1291– 300.
18. Min JK, Leipsic J, Pencina MJ, Berman DS, Koo BK, van Mieghem C, etal. Diagnostic accuracy of fractional ow reserve from anatomic CT angiography. JAMA. 2012;308(12):1237– 45.
19. Modolo R, Collet C, Onuma Y, Serruys PW. SYNTAX II and SYNTAX III trials:what is the take home message for surgeons? Ann Cardiothorac Surg. 2018;7(4):470– 82.
20. Stillman AE, Gatsonis C, Lima JA, Black WC, Cormack J, Gareen I, etal. Rationale and design of the Randomized Evaluation of patients with Stable angina Comparing Utilization of noninvasive Examinations (RESCUE) trial. Am Heart J. 2016;179: 19– 28.
https://t.me/medicina_free
https://t.me/medicina_free
6
Ischaemia, hibernation, andviability
Roberto Ferrari
It was dogma for many years that if myocardial ischaemia persists for more than 30 minutes, necrosis will develop, resulting in myo­cardial infarction. e unavoidable extrapolation of that dogma suggested that chronic ischaemia, in reality, cannot exist, as it will inevitably evolve into structural changes (i.e. irreversible damage). ese tenets were overturned in the early 1980s when Rahimtoola reviewed the results of coronary bypass surgery trials and identied patients with coronary artery disease and chronic le ventricular dysfunction persisting for months and even years that improved aer revascularization. e rapid amelioration of myocardial func­tion obtained by revascularization ruled out the hypothesis that the reduced function was due to histological modication of the myo­cardium and le the entire scientic community with the dilemma to explain and recognize hibernating myocardium.
Hibernation immediately attracted the attention of basic scientists and several experimental models and studies were quickly under­taken. us, Ross and Heusch described hibernating myocardium as the result of a proportionate reduction in blood supply and con­tractile function, the so called perfusion– contraction matching. is idea gained immediate consensus, both in the acute experimental models and in some clinical settings (i.e. short- term hibernation), while a chronic perfusion– contraction matching (i.e. chronic hi­bernation) resulted in a long- lasting and, to some extent, semantic controversy:reduced versus preserved baseline ow in hibernating myocardium.–  How could hibernation, which is an expression of ischaemia, exist in the presence of normal ow? Of course all de­pends on the denition of ischaemia and, amazingly, as late as 1994 there was no clear accepted denition of ischaemia. e majority of studies reported reduced resting ow in the hibernating segments, but others found no reduction. As a result, the idea that hiberna­tion is consequent to repetitive episodes of post- ischaemic stunning developed. Even this hypothesis seems unrealistic, as stunning and hibernation are distinct entities with respect to their origin and nat­ural history. Stunning occurs on reperfusion, hibernation needs re­perfusion to be established! Another mystery relates to the intrinsic cause and consequences of the downregulation of contractility of hibernating myocardium, which has been considered either ‘smart’ or ‘selsh’. ‘Smart’ because it is capable of adapting to unfavourable circumstances by appropriately downregulating its biochemical and physiological activity as an act of self- preservation. By contrast, for
the whole body or for the patient, this mechanism is unfavourable because it is aimed at preserving myocyte integrity at the expense of contraction and hence cardiac output. An interesting hypothesis to explain the intrinsic mechanism of the downregulation in contrac­tion relates to intracellular acidosis, which is known to compete and freeze calcium movements through all cell membranes. It has been suggested that the acute ischaemic insult (either angina or an acute coronary syndrome) that always precedes hibernation causes a drop of tissue pH which, in turn, reduces contraction and therefore energy need. ereaer, some collateral ow likely develops, though is not enough to restore normal pH, but enough to provide the mitochon­dria of quiescent non- contracting myocytes with the oxygen neces­sary to produce enough energy to maintain viability. Reperfusion at this stage restores normal pH and a prompt recovery of function. ese series of events, summarized in Fig. 6.1, have been shown in isolated and perfused rabbits hearts and conrmed in larger ani­mals., It is likely that in the human ischaemic tissue there is a continuum sequence of no- and low- ow ischaemia causing a sort of preconditioning with a consequent metabolic adaptation during the collateral- mediated low- ow phase. Such a sequence of meta­bolic adaptation has been shown in patients with hibernating myo­cardium subjected to surgical revascularization.
Whatever the mechanism, what matters is the separation of ‘hibernating’ and ‘stunned’ (viable) from infarcted (dead) myocar­dium and the identication of these entities has become a major clinical goal. In the early days of hibernation, a variety of techniques became available to detect viability and these can be broadly div­ided into two groups:(1) radioactive tracers of perfusion that de­pend on the integrity of the sarcolemma for myocardial uptake and retention (i.e. thallium or rubidium scintigraphy) or preservation of myocardial metabolism (i.e. positron emission tomography (PET)) and (2)characterization of the hypokinetic segments (i.e. wall thick­ness) with stimulants of inotropic reserve (i.e. post- extrasystolic po­tentiation and low- dose dobutamine stress echocardiography). e most recent technological developments in cardiovascular imaging have expanded the possibility to detect viability. PET, which assesses myocardial function, perfusion, and metabolism, is highly recom­mended for diagnosis of hibernation. Viable tissue metabolizes both free fatty acids and glucose, while dysfunctional myocytes de­pend on anaerobic glucose metabolism. By combining perfusion
SECTION 1 Pathophysiology and investigation ofcoronary artery disease54
Ischaemic insult
https://t.me/medicina_free
Acidosis
Pi
Akinetic
Reduction of oxygen
demand (mitochondrial oxidation)
Residual collateral flow
enough to support the
reduced mitochondrial
oxidation but not enough
to restore normal pH and Pi
Hibernation
Fig.6.1 Schematic representation of the role of akinesia in the
development of hibernation. Pi, inorganic phosphate.
tracer (usually nitrogen- 13 labelled ammonia or rubidium- 82) with uorodeoxyglucose, a glucose analogue, PET distinguishes normal (normal function, perfusion, and metabolism) from stunned (dys­functional but with normal perfusion and metabolism) and hiber­nating myocardium (diminished function and perfusion but normal free fatty acid metabolism). Cardiac magnetic resonance (CMR) also detects myocardial viability by means of delayed contrast enhance­ment or of dobutamine CMR. Delayed contrast- enhanced CMR assesses anatomical myocardial tissue as hibernating as opposed to infarcted myocardium when it has a normal distribution volume of contrast medium and does not demonstrate hyperenhancement. Similar to echocardiography, dobutamine CMR visualizes, with high spatial resolution and regional denition, wall motion and sys­tolic wall thickening. Cardiac computed tomography at present is not recommended to detect hibernation because of the radiation ex­posure and absence of studies proving its usefulness. In addition, recent soware has made it possible to merge CMR with nuclear imaging (single- photon emission computed tomography/ PET) datasets and most likely this new hybrid imaging will constitute the gold standard for detection of hibernation. Of course, all of these techniques have intrinsic pros and cons, require several degrees of knowledge, and have dierent complexity and costs. Nonetheless, from a pragmatic point of view, those testing the contractile reserve in addition to viability provide critically important information on the likelihood of recovery aer reperfusion/ revascularization.
It is relevant to underline that all of the currently employed diag­nostic techniques are just markers of myocardial viability. e only appropriate standard is recovery of function upon revascularization and, eventually, reduction in symptoms and improvement of sur­vival., Data related to the prognostic value of revascularization of hibernating myocardium are scanty. Two studies suggest a lower event rate in patients with areas of viable myocardium undergoing revascularization in comparison with those with similar areas of hibernation without revascularization., Another still grey area relates to the extension of viable myocardium required to be pre­sent to provide clinical benets once reperfused. Abetter outcome
aer surgical revascularization occurs mainly for patients with se­verely impaired ejection fraction. Ideally, the mass of myocardial viability should be (at least) more than 20% of the le ventricle to make the revascularization and its intrinsic risk worthwhile. e indication for revascularization is not limited to the presence of angina pectoris or inducible ischaemia, but also extends to those pa­tients with signs of heart failure, sometimes on the waiting list for transplantation. Indeed, a diagnosis of hibernation will drive clin­ical decision- making towards revascularization as an alternative to transplantation for patients with severe ischaemic cardiomyopathy.
Another unknown issue relating to hibernation is its actual prevalence. One thing is clear:not all hearts that are subjected to a restriction of coronary ow are able to survive and recover. Not surprisingly, there are few data on the incidence of hibernating my­ocardium. is is primarily due to the fact that the concept is rela­tively new, counterintuitive, not unanimously accepted, and there is no standard simple procedure for recognition of dysfunctional but still viable myocardium. Despite all these caveats, it appears that hi­bernation may be more common in unstable rather than stable an­gina. e incidence in non Q- wave myocardial infarction has been suggested to be 20%. About 15% of patients referred to cardiac transplantation have hibernating myocardium. ough available studies suggest that hibernation is a rare phenomenon, it is more frequent than originally thought and it is easier to miss than to nd it. e problem, once again, relies on the diculty in distinguishing between wall motion abnormalities due to real hibernation and those due to non- transmural myocardial infarction.
e treatment of hibernating myocardium should be by reper­fusion as no data exist about the ecacy of pharmacological treat­ment. eoretically, drugs that improve coronary ow and protect ischaemic myocytes should be useful, but may carry a risk to trigger arrhythmias. e knowledge that a large portion of dysfunctional myocardium is viable rather than brotic and that is likely to re­cover upon reperfusion has shed a completely new light onto the entire issue. Clinicians have long linked reduced systolic function to mortality and symptomatic status. But today, a low ejection fraction is no longer an absolute prognostic indicator of survival. e mechanisms by which reperfusion is benecial are multiple. Revascularization reduces the likelihood of new ischaemic episodes, allows contractile recovery of the myocardium, which is potentially viable, arrests any further deterioration in systolic function (or re­duces remodelling), and prevents lethal arrhythmias, typical of non­revascularized hibernating myocardium.
e original intuition of Rahitmoola in 1989 has radically changed the current physiopathological concept of myocardial is­chaemia and the treatment of some patients with coronary artery disease. Myocardial hibernation, non- transmural infarction, and normally functioning non- ischaemic myocardium probably all co­exist in patients with chronic le ventricular function. e available imaging techniques appear to be accurate markers for segments that contain viable myocardium and should be used more frequently to predict the success of revascularization. At present, the mech­anisms leading to hibernation are unknown. We need to clarify what the stimulus is and the signal transduction for hibernation and to discover the precise metabolic adaptation and the cause of downregulation of myocardial function, along with the roles of col­lateral ow and inammation. As Gerd Heusch stated, many more questions must be answered before exploitation of the hibernation
6 Ischaemia, hibernation, andviability 55
https://t.me/medicina_free
paradigm is possible. Doubtless Rahitmoola was not aware that he would raise so many questions when he described the results of his observations. is is the goal of great scientists:to observe and re­port phenomena even when they go against current dogmas and feed the scientic community with many questions.
11. Schulz R, Post H, Sakka S, Wallbridge DR, Heusch G. Intraischemic preconditioning. Increased tolerance to sustained low- ow ischemia by a brief episode of no- ow ischemia without intermittent reperfusion. Circ Res. 1995;76(6):942– 50.
12. Heusch G, Post H, Michel MC, Kelm M, Schulz R. Endogenous nitric oxide and myocardial adaptation to ischemia. Circ Res. 2000;87(2):146– 52.
Acknowledgement
13. Ceconi C, La Canna G, Aleri O, Cargnoni A, Coletti G, Curello S, etal Revascularization of hibernating myocardium:rate of metabolic and functional recovery and occurrence of oxidative
is work was supported by the Fondazione Anna Maria Sechi per il Cuore.
stress. Eur Heart J. 2002;23(23):1877– 85.
14. Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne- Nickens P, etal. Myocardial viability and survival in ischemic le ventricular dysfunction. N Engl J Med.
REFERENCES
1. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation. 1985;72(6 Pt 2, Suppl V):V123– 35.
2. Ross J Jr. Myocardial perfusion- contraction matching. Implications for coronary heart disease and hibernation. Circulation. 1991;83(3): 1076– 83.
3. Heusch G. Hibernating myocardium. Physiol Rev. 1998;78(4): 1055– 85.
4. Heusch G, Schulz R. Perfusion- contraction match and mismatch. Basic Res Cardiol. 2001;96(1):1– 10.
5. Camici PG, Wijns W, Borgers M, De Silva R, Ferrari R, Knuuti J, etal Pathophysiological mechanisms of chronic reversible le ventricular dysfunction due to coronary artery disease:hibernating myocardium. Circulation. 1997;96(9):3205– 14.
6. Schulz R, Post H, Neumann T, Gres P, Lüss H, Heusch G. Progressive loss of perfusion- contraction matching during sustained moderate ischemia in pigs. Am J Physiol Heart Circ Physiol. 2001;280(5):H1945– 53.
7. Hearse DJ. Myocardial ischemia:can we agree a denition for the 21st century? Cardiovasc Res. 1994;28(12):1737– 44:discussion 1745.
8. Shen YT, Vatner SF. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs:hibernation versus stunning. Circ Res. 1995;76(3):479– 88.
9. Ferrari R. e search for the hibernating myocardium— have we reached the limit? Cardiovasc Drugs er. 1999;13(2):137– 43.
10. Ferrari R, Cargnoni A, Bernocchi P, Pasini E, Curello S, Ceconi C,
2011;364(17):1617– 25.
15. Hussain ST, Chiribiri A, Morton G, Bettencourt N, Schuster A, Paul M, etal. Perfusion cardiovascular magnetic resonance and fractional ow reserve in patients with angiographic multi- vessel coronary artery disease. J Cardiovasc Magn Reson. 2016;18(1):44.
16. Pinto FJ. Myocardial viability:the search for a perfect method is not over yet. Eur Heart J. 2000;21(13):1039– 40.
17. Armstrong WF. ’Hibernating’ myocardium:asleep or part dead? J Am Coll Cardiol. 1996;28(2):530– 5.
18. Ferrari R, Ferrari F, Benigno M, Pepi P, Visioli O. Hibernating myocardium:its pathophysiology and clinical role. Mol Cell Biochem. 1998;186(1– 2):195– 9.
19. Eitzman D, Al- Aouar Z, Kanter HL, vom Dahl J, Kirsh M, Deeb GM, etal. Clinical outcome of patients with advanced coronary artery disease aer viability studies with positron emission tomography. J Am Coll Cardiol. 1992;20(3):559– 65.
20. Di Carli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, etal. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and le ventricular dysfunction. Am J Cardiol. 1994;73(8):527– 33.
21. La Canna G, Aleri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identication of reversibly dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol. 1994;23(3):617– 26.
22. Ferrari R, Ceconi C, Curello S, Benigno M, La Canna G, Visioli O. Le ventricular dysfunction due to the new ischemic outcomes: stunning and hibernation. J Cardiovasc Pharmacol. 1996;28(Suppl 1):S18– 26.
23. Rahimtoola SH. Hibernating myocardium:a brief article. Basic Res Cardiol. 1995;90(1):38– 40.
ow ischaemia:a possible trigger for hibernation. Circulation. 1996;94(10):2587– 96.
24. Heusch G, Schulz R. Hibernating myocardium:new answers, still more questions! Circ Res. 2002;91(10):863– 5.
https://t.me/medicina_free
https://t.me/medicina_free
7
Invasive investigation ofcoronary arterydisease
7.1 Angiography
Normal angiographic anatomy ofthe left and right coronaryarteries
Matthew I. Tomey
Normal angiographic anatomy of the native le and right cor-
Diagnostic coronary angiography:a briefhistory
‘As an aid to diagnosis in ischaemic heart- disease’, Lancet editorial­ists wrote in 1966, coronary angiography ‘seems at present to oer little that cannot be more easily obtained by much simpler methods, such as good history- taking and electrocardiography’. Since its ser­endipitous origins at the Cleveland Clinic laboratory of Dr F.Mason Sones in 1958, selective coronary angiography has taken on central importance in the diagnosis of coronary artery disease and charac­terization of coronary anatomy prior to coronary artery bypass gra surgery. Performance has become simpler and safer, evolving from a brachial artery cut- down approach with sti, large- calibre multi­purpose catheters to percutaneous femoral, radial, and now ulnar approaches with soer, lower- prole catheters specially designed to atraumatically engage the coronary ostia.
Procedureoverview
First, arterial access is obtained by the modied Seldinger tech­nique, most commonly via the femoral or radial artery. In a retrograde fashion, a coronary catheter is then advanced over a guidewire through the percutaneous introducer sheath to the as­cending aorta. ere, aer de- airing the catheter, the catheter tip is engaged in the ostium of the right or le coronary artery under uoroscopic guidance. Radiocontrast medium is selectively injected into the coronary artery, with motion picture recording of injections (‘cineangiography’) in multiple views. e process is repeated for the other coronary artery. is can be accomplished with a single multipurpose catheter or with specialized le and right catheters. Coronary angiography is oen paired with insertion of a catheter into the le ventricle to record pressures, with or without contrast ventriculography (‘le heart catheterization’). When there has been previous coronary artery bypass gra surgery, gra angiography can be performed in a similar fashion and in the same setting.
onary arteries is depicted in Fig. 7.1.1. Due to compression of the three- dimensional anatomy of the coronary vasculature into a two- dimensional lm, single views are subject to overlap and foreshortening. Proper coronary angiography requires multiple views of each coronary artery to permit complete visualization.
Angiographic diagnosis and classification ofcoronarylesions
Coronary angiography illustrates not the artery itself, but rather the opacication of its lumen. Diagnosis, grading, and classica­tion of coronary lesions, accordingly, derive from deviations in the expected smooth, tapering, branching contour of the coronary lumen.
Coronary lesions appear as a reduction in luminal diameter rela­tive to the reference vessel diameter. Common categories for visu­ally estimated diameter stenosis include less than 30%, 30– 50%, 50– 60%, 60– 70%, 70– 80%, 80– 90%, 90– 95%, 99% (subtotal occlu­sion, with slow ow), and 100% (total occlusion, with no ow), with greater than 70% stenosis typically considered angiographically sig­nicant (or >50% for the le main coronary artery). Stenosis of less than 50% is typically considered ‘non- obstructive’, whereas inter­mediate stenosis of 50– 70% may require additional testing to deter­mine functional signicance. Whereas some lesions are concentric, others are eccentric, appearing mild or absent in orthogonal views; accordingly, the assigned grade of a given stenosis is taken from the view in which it appears most severe.
Coronary angiography is eective for demonstrating and grading not only stenosis severity but also complex lesion features which increase diculty and risk of percutaneous coronary intervention (PCI). Examples include calcication, bifurcation morphology, and chronic total occlusion (Fig. 7.1.2). e Synergy Between PCI With TAXUS and Cardiac Surgery (SYNTAX) score aggregates angiographic data on the extent and complexity of coronary artery disease into a single semiquantitative score useful in triage to PCI versus coronary artery bypass graing.